Studies have demonstrated that microglia are the predominant source of NF-κB signaling in animal models of neurodegeneration such as amyotrophic lateral sclerosis and tauopathy, and inhibition of this pathway in microglia in these models proves neuroprotective [1,2]. Here, NFKB1 is linked to amyotrophic lateral sclerosis.